SG Americas Securities’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $135K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $507K | Buy |
|
|||||
|
2024
Q2 | $118K | Sell |
|
|||||
|
2024
Q1 | $149K | Sell |
|
|||||
|
2023
Q4 | $158K | Buy |
|
|||||
|
2023
Q3 | $83K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $112K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $1.49M | Buy |
|
|||||
|
2022
Q1 | $1.28M | Sell |
|
|||||
|
2021
Q4 | $2.36M | Buy |
|
|||||
|
2021
Q3 | $1.15M | Buy |
|
|||||
|
2021
Q2 | $307K | Sell |
|
|||||
|
2021
Q1 | $1.23M | Sell |
|
|||||
|
2020
Q4 | $1.44M | Buy |
|
|||||
|
2020
Q3 | $836K | Buy |
|
|||||
|
2020
Q2 | $258K | Sell |
|
|||||
|
2020
Q1 | $1.12M | Buy |
|
|||||
|
2019
Q4 | $189K | Sell |
|
|||||
|
2019
Q3 | $189K | Buy |
|
|||||
|
2019
Q2 | $149K | Sell |
|
|||||
|
2019
Q1 | $292K | Sell |
|
|||||
|
2018
Q4 | $993K | Buy |
|
|||||
|
2018
Q3 | $127K | Sell |
|
|||||
|
2018
Q2 | $192K | Buy |
|
|||||
|
2018
Q1 | $171K | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $202K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $278K | Buy |
|
|||||
|
2016
Q3 | $246K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $138K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $201K | Buy |
|